IHT SA PTCA Balloon Catheter — Swiss Precision in Interventional Cardiology A high-performance coronary angioplasty (PTCA) balloon catheter manufactured by IHT SA (Switzerland). This device is engineered for the precise dilation of stenosed arteries and effective restoration of blood flow during complex interventional procedures. Key Benefits: Superior Navigation: The flexible shaft with a hydrophilic coating ensures smooth trackability and delivery through the most tortuous coronary anatomies. Low-Profile Design: An ultra-thin, low-profile balloon segment allows for exceptional crossability through tight lesions. Controlled Dilation: Designed for stable performance at pressures ranging from 6 to 20 atm, ensuring effective compression of atherosclerotic plaques. Advanced Visualization: A radiopaque marker band ensures accurate positioning under fluoroscopic guidance. Universal Compatibility: Fully compatible with standard 0.014" guidewires and inflation devices featuring a Luer connector.
IHT Central Asia LLP is a Kazakh-Spanish joint venture and the only manufacturer of coronary stents and balloon catheters in Central Asia, established in 2023. The company produces high-tech interventional cardiology devices based on European technology transfer. Production is localized in Astana and focused on treating ischemic heart disease and preventing myocardial infarction. Product range: Drug-eluting coronary stents (DEStiny) Balloon catheters for angioplasty (Evolve) Solutions for percutaneous coronary interventions Key advantages: Unique regional manufacturer Proven European technology and clinical validation Coverage of Kazakhstan demand (up to 36,000 stents/year) Up to 30% lower cost than imports Export to Central Asia and other markets IHT Central Asia delivers advanced cardiovascular solutions focused on technology, accessibility, and reliability for healthcare systems.
